gliclazide has been researched along with indomethacin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, Y; Feng, F; Guo, Q; He, S; Liu, W; Liu, Y; Sun, H; Zhao, L | 1 |
| Angulo, J; Nevado, J; Peiró, C; Petidier, R; Rodríguez-Mañas, L; Sánchez-Ferrer, A; Sánchez-Ferrer, CF; Vallejo, S | 1 |
| Gangwar, U; Kurur, ND; Singh, B | 1 |
| Griffith, TM; Taylor, HJ | 1 |
| Chaytor, AT; Evans, WH; Griffith, TM; Martin, PE; Randall, MD | 1 |
| Chaytor, AT; Griffith, TM; Hutcheson, IR; Marsh, WL | 1 |
| Dusting, GJ; Jiang, F | 1 |
| Ahluwalia, A; Chauhan, S; Scotland, RS; Vallance, PJ | 1 |
| Baker, PN; Dunn, WR; Kendall, DA; Kenny, LC; Randall, MD | 1 |
| Hultenby, K; Kublickas, M; Kublickiene, K; Luksha, L; Luksha, N; Nisell, H | 1 |
| Fujiwara, H; Hashikawa-Hobara, N; Kawasaki, H; Kitamura, Y; Makino, K; Takatori, S; Wake, Y; Zamami, Y | 1 |
| Nishida, S; Satoh, H | 1 |
| Azuma, T; Inoue, J; Ishida, T; Kawauchi, S; Kondo, Y; Maeda, H; Miki, I; Mizuno, S; Nakayama, H; Nishiumi, S; Takeuchi, A; Tanahashi, T; Tode, C; Yagi, S; Yoshida, M | 1 |
| Randall, MD; Roberts, RE; Wong, PS | 1 |
1 review(s) available for gliclazide and indomethacin
| Article | Year |
|---|---|
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Binding Sites; Cell Proliferation; Clinical Trials as Topic; Drug Development; Drug Resistance, Neoplasm; Humans; Models, Molecular; Molecular Structure; Neoplasms; Treatment Outcome | 2020 |
21 other study(ies) available for gliclazide and indomethacin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels.
Topics: Animals; Ascorbic Acid; Bradykinin; Catalase; Free Radical Scavengers; Gliclazide; Glycated Hemoglobin; Humans; In Vitro Techniques; Indomethacin; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Omentum; Potassium Chloride; Rats; Splanchnic Circulation; Superoxide Dismutase; Thiourea; Vasodilation | 2000 |
Long-Lived States Provide Insights from NMR into the β-Cyclodextrin Drug Assemblies.
Topics: Acetaminophen; beta-Cyclodextrins; Gliclazide; Indomethacin; Magnetic Resonance Spectroscopy | 2023 |
Cyclic AMP mediates EDHF-type relaxations of rabbit jugular vein.
Topics: Acetylcholine; Animals; Biological Factors; Colforsin; Cyclic AMP; Endothelium, Vascular; Gap Junctions; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Jugular Veins; Male; Models, Biological; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Rabbits; Vasodilation; Vasodilator Agents | 1999 |
The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.
Topics: Acetylcholine; Animals; Arachidonic Acids; Benzofurans; Cannabinoid Receptor Modulators; Cannabinoids; COS Cells; Endocannabinoids; Gap Junctions; Glycyrrhetinic Acid; Indomethacin; Isoquinolines; Male; Mesenteric Artery, Superior; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Phenylephrine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rabbits; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1999 |
Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions.
Topics: Acetylcholine; Animals; Biological Factors; Carbenoxolone; Gap Junctions; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Isomerism; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitroprusside; Phenylephrine; Rabbits; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2000 |
Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.
Topics: Acetylcholine; Animals; Barium; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium; Enzyme Inhibitors; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Ouabain; Oxadiazoles; Potassium; Quinoxalines; Rats; Rats, Inbred WKY; Renal Artery; Vasodilation; Vasodilator Agents | 2001 |
An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apamin; Barium; Biological Factors; Calcium; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Genotype; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Penicillamine; Potassium Channel Blockers; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |
The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Biological Factors; Bradykinin; Cannabinoids; Carbenoxolone; Clotrimazole; Cyclooxygenase Inhibitors; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; In Vitro Techniques; Indomethacin; Myometrium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Piperidines; Pregnancy; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasoconstrictor Agents; Vasodilation | 2002 |
Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites.
Topics: Adolescent; Adult; Arachidonic Acid; Arteries; Biological Factors; Biopsy; Bradykinin; Cardiovascular Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; Hydrogen Peroxide; In Vitro Techniques; Indomethacin; Microscopy, Electron, Transmission; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pre-Eclampsia; Pregnancy; Vasodilation; Vasodilator Agents | 2008 |
Endothelium-derived relaxing factor-mediated vasodilation in mouse mesenteric vascular beds.
Topics: Acetylcholine; Animals; Biological Factors; Calcimycin; Calcium Ionophores; Cyclooxygenase Inhibitors; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Enzyme Inhibitors; Gap Junctions; Glyburide; Glycyrrhetinic Acid; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Potassium Channel Blockers; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2012 |
Role of gap junction involved with endothelium-derived hyperpolarizing factor for the quercetin-induced vasodilatation in rat mesenteric artery.
Topics: Animals; Antioxidants; Biological Factors; Gap Junctions; Glycyrrhetinic Acid; Indomethacin; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Quercetin; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2013 |
Effect of 18β-glycyrrhetinic acid and hydroxypropyl γcyclodextrin complex on indomethacin-induced small intestinal injury in mice.
Topics: Animals; Biological Availability; gamma-Cyclodextrins; Gene Expression Regulation; Glycyrrhetinic Acid; Indomethacin; Interleukin-1beta; Interleukin-6; Intestine, Small; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Solubility; Tumor Necrosis Factor-alpha | 2013 |
Sex differences in endothelial function in porcine coronary arteries: a role for H2O2 and gap junctions?
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apamin; Bradykinin; Carbenoxolone; Catalase; Connexins; Coronary Vessels; Endothelium, Vascular; Female; Gap Junctions; Glycyrrhetinic Acid; Hydrogen Peroxide; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Polyethylene Glycols; Pyrazoles; Sex Characteristics; Swine; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2014 |